Years of losses, thin profit margins leave 160 Health feeling down
After two earlier failures, the online healthcare platform’s IPO has been approved by the Hong Kong Stock Exchange Key Takeaways: 160 Health has been approved to list in Hong Kong,…
BRIEF: YSB Inc.’s profit triples in first half of 2025
Pharmaceutical e-commerce platform YSB Inc. (9885.HK) announced on Thursday that it expects to record a net profit of 70 million yuan ($9.75 million) or more for the six months through…
BRIEF: Dobot partners with YSB on pharmacy-focused robots
Robot manufacturer Shenzhen Dobot Corp. Ltd. (2432.HK) on Tuesday announced a strategic collaboration with YSB Inc. (9885.HK) to jointly develop robots for pharmaceutical applications. The partnership will see Dobot spearhead…
Recent Articles
RELATED ARTICLES
-
ShanH seeks IPO recharge after years of losses
- PomDoc offers up well-conceived but overvalued digital healthcare IPO
- Pateo Connect revs up for IPO, belching widening losses and slumping margins
-
Nio’s road to profitability obscured in haze of losses
9866.HK NIO.US
- Anew Health taps investor ‘Qi’ with Nasdaq listing plan
-
From ‘magic tea’ to dietary drugs, can Besunyen reclaim its glory days？
0926.HK
